Osteoporosis

Latest News

osteoporosis
FDA accepts BLA for Sandoz proposed denosumab biosimilar

February 6th 2023

The US Food and Drug Administration has accepted the Biologics License Application (BLA) for a proposed biosimilar of denosumab (Prolia and Xgeva; Amgen) for treatment of various conditions.

Study finds global hip fractures expected to double by 2050
Study finds global hip fractures expected to double by 2050

September 13th 2022

NSAID use may reduce effectiveness of osteoporosis therapies
NSAID use may reduce effectiveness of osteoporosis therapies

May 9th 2022

Common pain-relief drugs may reduce effectiveness of osteoporosis medications
Common pain-relief drugs may reduce effectiveness of osteoporosis medications

April 29th 2022

Metabolite profiling of osteoporosis and atherosclerosis
Metabolite profiling of osteoporosis and atherosclerosis

December 30th 2020

More News

© 2023 MJH Life Sciences

All rights reserved.